ChemAbout

ChemAbout is a B2B platform where chemical buyers and suppliers discover each other.

Post a purchase requestList your products (for suppliers)
© 2026 ChemAbout
Compound Index|Demand Board|Insights|Exhibitions|Compliance|Help Center|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/Research Reagent/2-amino-n-(1-{[5-(6-amino-9h-purin-9-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl]amino}-1-oxopropan-2-yl)-3-phenylpropanamide(non-preferred name)
C22H28N8O5
484.5 g/mol
Research Reagent

2-Amino-N-(1-{[5-(6-amino-9H-purin-9-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]amino}-1-oxopropan-2-yl)-3-phenylpropanamide

CAS28342-90-7
Category
Research Reagent
Compound Class
Peptide
Primary Use
Research Compound

This compound is a reference standard used for the identification of impurities in adenosine. It is a research reagent with a complex structure containing multiple polar functional groups and aromatic rings.

Reference standard for adenosine impurity analysis in pharmaceutical research

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing this compound?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→

Related Compounds

ReferenceSame Category

4-Aminobenzamide

CAS2835-68-9

research compound

ReferenceSame Category

5-Chloro-2,3-dimethoxypyridine

CAS284040-73-9

research compound

ReferenceSame Category

9-Bromo-2,3-dimethoxy-7,7-dipropyl-7H-benzo[c]fluoren-5-ol

CAS2840628-05-7

research compound

ReferenceSame Category

Hexadecacarbonylhexarhodium

CAS28407-51-4

research compound

Related Reading

Therapeutic Peptides in 2026: This Year's Breakthroughs

2026 has been a concentrated year for peptide therapeutics. Efficacy reached a new high in late-stage trials, the obesity field moved beyond the incretins to amylin, the oral route reached weight management, and peptide-guided radioligand therapy kept advancing — each point tied to a specific 2025–2026 result.

Read more
Identifiers
IUPAC Name

2-amino-N-[1-[[5-(6-aminopurin-9-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]amino]-1-oxopropan-2-yl]-3-phenylpropanamide

InChIKey

WZBDAPCJMJWCPA-UHFFFAOYSA-N

SMILES

CC(C(=O)NC1C(OC(C1O)N2C=NC3=C(N=CN=C32)N)CO)NC(=O)C(CC4=CC=CC=C4)N

Synonyms (2)

—

Sourcing this compound?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→